Takeda's CEO under pressure & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Innovate Biopharmaceuticals agreed to acquire Monster Digital, an electronic camera and data storage company.

Forest Laboratories and Allergan filed a suit against Sun Pharma for patent infringement in the District of Delaware's U.S. District Court.

Takeda Pharmaceuticals President and CEO Christophe Weber could face increased scrutiny after the retirement of Chairman Yasuchika Hasegawa.

The FDA approved Salix Pharmaceuticals' new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.

Medial EarlySign entered into a strategic collaboration with Medicover for a pilot program aimed at identifying individuals with a high colorectal cancer risk.

More articles on gastroenterology:
Drs. Arnold Rosen, Akash Patel & more: 3 GI physicians making news
5 most read GI/endoscopy stories: June 26 — June 30, 2017
GI leader to know: Dr. Mark Marino of Metropolitan Gastroenterology Associates

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers